New Drug Applications Archive - November 2012
Get news by email or subscribe to our news feeds.
November 1, 2012
November 2, 2012
November 7, 2012
November 8, 2012
November 13, 2012
November 14, 2012
- FDA Accepts Noven's NDA For An Investigational Nonhormonal Therapy For Menopausal Vasomotor Symptoms
November 16, 2012
- Dynavax Announces FDA Advisory Committee Meeting Outcome for Heplisav
- Zogenix Announces FDA Advisory Committee Review of Zohydro ER for the Management of Chronic Pain
November 19, 2012
November 28, 2012
- AVEO and Astellas Announce FDA Acceptance of NDA Filing for Tivozanib for the Treatment of Advanced Renal Cell Carcinoma
- Forest Laboratories Submits New Drug Application for Cariprazine for the Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder
